1. Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network. Issue 18 (28th June 2021) Authors: Gay, Francesca; Günther, Andreas; Offidani, Massimo; Engelhardt, Monika; Salvini, Marco; Montefusco, Vittorio; Patriarca, Francesca; Aquino, Sara; Pönisch, Wolfram; Spada, Stefano; Schub, Natalie; Gentili, Silvia; Wäsch, Ralph; Corradini, Paolo; Straka, Christian; Palumbo, Antonio; Einsele, Herma... Journal: Cancer Issue: Volume 127:Issue 18(2021) Page Start: 3413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Issue 10 (October 2020) Authors: Passamonti, Francesco; Cattaneo, Chiara; Arcaini, Luca; Bruna, Riccardo; Cavo, Michele; Merli, Francesco; Angelucci, Emanuele; Krampera, Mauro; Cairoli, Roberto; Della Porta, Matteo Giovanni; Fracchiolla, Nicola; Ladetto, Marco; Gambacorti Passerini, Carlo; Salvini, Marco; Marchetti, Monia; Lemol... Journal: Lancet Issue: Volume 7:Issue 10(2020) Page Start: e737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies. (16th July 2021) Authors: Passamonti, Francesco; Romano, Alessandra; Salvini, Marco; Merli, Francesco; Porta, Matteo G. Della; Bruna, Riccardo; Coviello, Elisa; Romano, Ilaria; Cairoli, Roberto; Lemoli, Roberto; Farina, Francesca; Venditti, Adriano; Busca, Alessandro; Ladetto, Marco; Massaia, Massimo; Pinto, Antonio; Arca... Other Names: Derenzini Enrico investigator.; Marchetti Monia investigator.; Scattolin Anna M. investigator.; Corso Alessandro investigator.; Tosi Patrizia investigator.; Gherlinzoni Filippo investigator.; Passerini Carlo Gambacorti investigator.; Cavo Michele investigator.; Fava Carmen investigator.; Turrini ... Journal: British journal of haematology Issue: Volume 195:Number 3(2021) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Determining treatment intensity in elderly patients with multiple myeloma. Issue 9 (2nd September 2018) Authors: Salvini, Marco; D'Agostino, Mattia; Bonello, Francesca; Boccadoro, Mario; Bringhen, Sara Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 9(2018) Page Start: 917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunogenicity and clinical efficacy of anti‐SARS‐CoV‐2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients. Issue 8 (24th June 2022) Authors: Salvini, Marco; Damonte, Camilla; Mortara, Lorenzo; Maggi, Fabrizio; Bruno, Antonino; Pellegrini, Giacomo; Mora, Barbara; Brociner, Marco; Ingrassia, Alessia; Mattarucchi, Roberta; Bianchi, Benedetta; Sirocchi, Davide; Agnoli, Stefania; Rumi, Elisa; Merli, Michele; Fossati, Alessandro; Bassi, Sus... Journal: American journal of hematology Issue: Volume 97:Issue 8(2022) Page Start: E321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma. Issue 1 (2nd January 2017) Authors: Salvini, Marco; Bonello, Francesca; Boccadoro, Mario; Larocca, Alessandra Journal: Expert review of anticancer therapy Issue: Volume 17:Issue 1(2017) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Melphalan hydrochloride for the treatment of multiple myeloma. (24th July 2017) Authors: Esma, Fabrizio; Salvini, Marco; Troia, Rossella; Boccadoro, Mario; Larocca, Alessandra; Pautasso, Chiara Journal: Expert opinion on pharmacotherapy Issue: Volume 18:Number 11(2017) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MULTIPLE MYELOMA PATIENTS UNDERGOING CARFILZOMIB: VALIDATION OF A MANAGEMENT PROTOCOL FOR CARDIOVASCULAR RISK ASSESSMENT AND A NEW SCORE FOR EVENTS PREDICTION. (April 2021) Authors: Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Vallelonga, Fabrizio; Bruno, Giulia; Leone, Dario; Giordana, Carlo; Rabbia, Franco; Salvini, Marco; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto Journal: Journal of hypertension Issue: Volume 39(2021)e-Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study. (30th July 2022) Authors: Marasco, Vincenzo; Piciocchi, Alfonso; Candoni, Anna; Pagano, Livio; Guidetti, Anna; Musto, Pellegrino; Bruna, Riccardo; Bocchia, Monica; Visentin, Andrea; Turrini, Mauro; Tucci, Alessandra; Pilerci, Sofia; Fianchi, Luana; Salvini, Marco; Galimberti, Sara; Coviello, Elisa; Selleri, Carmine; Luppi... Journal: British journal of haematology Issue: Volume 199:Number 1(2022) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel investigational drugs active as single agents in multiple myeloma. (3rd June 2017) Authors: D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca Journal: Expert opinion on investigational drugs Issue: Volume 26:Number 6(2017) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗